Receptor, Cannabinoid, CB2
"Receptor, Cannabinoid, CB2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.
| Descriptor ID |
D043885
|
| MeSH Number(s) |
D12.776.543.750.695.125.200
|
| Concept/Terms |
Receptor, Cannabinoid, CB2- Receptor, Cannabinoid, CB2
- CB2 Receptor
- Receptor, CB2
- Cannabinoid Receptor CB2
- CB2, Cannabinoid Receptor
- Receptor CB2, Cannabinoid
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Cannabinoid, CB2".
Below are MeSH descriptors whose meaning is more specific than "Receptor, Cannabinoid, CB2".
This graph shows the total number of publications written about "Receptor, Cannabinoid, CB2" by people in this website by year, and whether "Receptor, Cannabinoid, CB2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, Cannabinoid, CB2" by people in Profiles.
-
Rosario-Rodr?guez LJ, Gerena Y, Garc?a-Requena LA, Cartagena-Isern LJ, Cuadrado-Ruiz JC, Borges-V?lez G, Mel?ndez LM. Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. Sci Rep. 2022 01 07; 12(1):233.
-
Ho TC, Tius MA, Nikas SP, Tran NK, Tong F, Zhou H, Zvonok N, Makriyannis A. Oxa-adamantyl cannabinoids. Bioorg Med Chem Lett. 2021 04 15; 38:127882.
-
Khatri D, Laroche G, Grant ML, Jones VM, Vetreno RP, Crews FT, Mukhopadhyay S. Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling. Alcohol Clin Exp Res. 2018 Apr; 42(4):718-726.
-
Scarlett KA, White EZ, Coke CJ, Carter JR, Bryant LK, Hinton CV. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Ga13/RhoA-mediated Migration. Mol Cancer Res. 2018 04; 16(4):728-739.
-
Nogueras-Ortiz C, Roman-Vendrell C, Mateo-Semidey GE, Liao YH, Kendall DA, Yudowski GA. Retromer stops beta-arrestin 1-mediated signaling from internalized cannabinoid 2 receptors. Mol Biol Cell. 2017 Nov 15; 28(24):3554-3561.
-
Ho TC, Shimada N, Tius MA, Nikas SP, Zhang W, Makriyannis A. C1'-Azacycloalkyl Hexahydrocannabinols. J Org Chem. 2017 08 04; 82(15):7839-7849.
-
Quraishi SA, Paladini CA. A Central Move for CB2 Receptors. Neuron. 2016 05 18; 90(4):670-1.
-
Coke CJ, Scarlett KA, Chetram MA, Jones KJ, Sandifer BJ, Davis AS, Marcus AI, Hinton CV. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression. J Biol Chem. 2016 May 06; 291(19):9991-10005.
-
Fujii M, Sherchan P, Soejima Y, Doycheva D, Zhao D, Zhang JH. Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats. Acta Neurochir Suppl. 2016; 121:135-9.
-
Hong J, Nandiwada V, Jones V, Lu M, Warner DS, Mukhopadhyay S, Sheng H. CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery. Neurosci Lett. 2015 Jun 15; 597:19-24.